Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2Q20

Structure of the germline Vk1 O18/O8 light chain variable domain homodimer

2Q20 の概要
エントリーDOI10.2210/pdb2q20/pdb
関連するPDBエントリー2Q1E
分子名称Vk1 O18/O8 germline light chain variable domain (2 entities in total)
機能のキーワードvk1, germline, al, light chain amyloidosis, amyloid, immunoglobulin, light chain, light chain variable domain, protein fibril
由来する生物種Homo sapiens (human)
細胞内の位置Secreted : P01594
タンパク質・核酸の鎖数2
化学式量合計23942.24
構造登録者
Thompson, J.R.,Ramirez-Alvarado, M.,Baden, E.M. (登録日: 2007-05-25, 公開日: 2008-04-08, 最終更新日: 2024-11-20)
主引用文献Baden, E.M.,Owen, B.A.,Peterson, F.C.,Volkman, B.F.,Ramirez-Alvarado, M.,Thompson, J.R.
Altered dimer interface decreases stability in an amyloidogenic protein.
J.Biol.Chem., 283:15853-15860, 2008
Cited by
PubMed Abstract: Amyloidoses are devastating and currently incurable diseases in which the process of amyloid formation causes fatal cellular and organ damage. The molecular mechanisms underlying amyloidoses are not well known. In this study, we address the structural basis of immunoglobulin light chain amyloidosis, which results from deposition of light chains produced by clonal plasma cells. We compare light chain amyloidosis protein AL-09 to its wild-type counterpart, the kappaI O18/O8 light chain germline. Crystallographic studies indicate that both proteins form dimers. However, AL-09 has an altered dimer interface that is rotated 90 degrees from the kappaI O18/O8 dimer interface. The three non-conservative mutations in AL-09 are located within the dimer interface, consistent with their role in the decreased stability of this amyloidogenic protein. Moreover, AL-09 forms amyloid fibrils more quickly than kappaI O18/O8 in vitro. These results support the notion that the increased stability of the monomer and delayed fibril formation, together with a properly formed dimer, may be protective against amyloidogenesis. This could open a new direction into rational drug design for amyloidogenic proteins.
PubMed: 18400753
DOI: 10.1074/jbc.M705347200
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.3 Å)
構造検証レポート
Validation report summary of 2q20
検証レポート(詳細版)ダウンロードをダウンロード

239149

件を2025-07-23に公開中

PDB statisticsPDBj update infoContact PDBjnumon